Skip to content

The COMPASSION Study

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients With Metastatic Breast Cancer Receiving Hospice Care

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06507930
Enrollment
200
Registered
2024-07-18
Start date
2024-09-01
Completion date
2027-03-01
Last updated
2025-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Breast Cancer, Breast Cancer, Metastatic Breast Cancer, Unresectable Breast Carcinoma

Keywords

Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Breast Cancer, Hospice Care

Brief summary

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Detailed description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams. Study procedures include giving verbal consent to participate and a one-time survey delivered by email or phone call. About 200 people, which includes 50 participants, 50 caregivers, 50 hospice nurses, and about 50 oncology providers, are expected to participate in this research study.

Interventions

OTHERTelehealth Hospice Visits

Telehealth check-in appointments with oncology care team, MD, PA, NP, or hospice nurse, via HIPAA compliant telehealth platform, Zoom, or by phone call.

Sponsors

Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient of any gender with unresectable locally advanced or metastatic breast cancer * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment * Ability to conduct video or phone check-ins, even if assistance required. * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able * Hospice setting is within Massachusetts * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment

Exclusion criteria

* Unable to provide verbal consent * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting) * Hospice setting outside of Massachusetts * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Design outcomes

Primary

MeasureTime frameDescription
Proportion of Participant Intervention CompletionUp to 4 weeksFeasibility of the telehealth intervention is defined as greater than or equal to 80% of enrolled participants (18 out of 25) completing greater than or equal to 66% of the planned telehealth check-ins while the participant remains alive.

Countries

United States

Contacts

Primary ContactClaire Smith, MD
claire_smith@dfci.harvard.edu617-632-3800

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026